39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
about
Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake.Effect of human acetylcholinesterase subunit assembly on its circulatory residenceMechanisms regulating plasminogen activators in transformed retinal ganglion cells.Agile delivery of protein therapeutics to CNSApolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model.The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor.Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway.Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo.Analysis of the binding of pro-urokinase and urokinase-plasminogen activator inhibitor-1 complex to the low density lipoprotein receptor-related protein using a Fab fragment selected from a phage-displayed Fab library.Receptor-associated protein interacts with amyloid-beta peptide and promotes its cellular uptake.LRP1 modulates the microglial immune response via regulation of JNK and NF-κB signaling pathways.Lipoprotein receptor binding, cellular uptake, and lysosomal delivery of fusions between the receptor-associated protein (RAP) and alpha-L-iduronidase or acid alpha-glucosidase.Cerebral clearance of human amyloid-beta peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes.Tissue-type plasminogen activator: a role for O-linked fucose.Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes.The role of the finger and growth factor domains in the clearance of tissue-type plasminogen activator by hepatocytes.C1 inhibitor-C1s complexes are internalized and degraded by the low density lipoprotein receptor-related protein.FG-3019, a Human Monoclonal Antibody Recognizing Connective Tissue Growth Factor, is Subject to Target-Mediated Drug Disposition.O-linked L-fucose is present in Desmodus rotundus salivary plasminogen activator.Interaction of mutants of tissue-type plasminogen activator with liver cells: effect of domain deletions.Analysis of a novel mechanism of neuronal toxicity produced by an apolipoprotein E-derived peptide.Minireview
P2860
Q29976923-488CEAC3-110F-4762-85C4-798286D5A406Q30657236-89989E20-F89B-4958-8A37-8AD01783BE2AQ33317890-BC44C2E9-2469-4917-93AC-CE846FF30532Q34079647-1BCAD30E-1FE8-483D-BFD5-A27871A58A5DQ34978900-53604C58-0FEA-4686-8F3B-6630D73E8F23Q35589734-CEE0C0F5-29F2-4A0D-A07E-6B19C5BE7570Q35662397-FD2D58ED-312E-4895-B5F1-FE215429CE6AQ35753604-87FE76EC-1490-44F7-A492-724C070F2B92Q36678418-9A26603B-C8AE-46A7-B0B9-FD1C1FB33F6EQ37446156-107E7662-2FE5-452A-9BDF-62DE53294721Q37487912-F545EEB0-D6F4-4C33-A474-37B014F3E278Q38340653-BB7A5B99-78DC-42B1-91B3-A0DCA62427E5Q40073861-DE5DE204-0F07-4986-A226-76B245336342Q40334147-DDBEDF64-A9C3-439D-96A6-710F3EE16EAAQ40814192-AE45B715-3B52-4481-8D52-E223BE741E08Q41272802-5778C3EC-26F3-4791-BF6C-3DAC99FC5F85Q41927379-D29DF622-145C-4E65-B192-0E57C719C1F7Q42424619-F6D513DC-BE9A-4B03-9C48-CD7E86134DA7Q42556462-B038FF0F-2C43-4F27-9AB3-60ED9136B270Q42980803-9DEA25EF-51C8-41E9-ACE5-721490A7327BQ48275574-22E58265-ECF6-4D26-BC9E-0CA4E106AC55Q58883739-68D90789-A59D-453E-A5C6-176FEF779886
P2860
39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
name
39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
@ast
39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
@en
39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
@nl
type
label
39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
@ast
39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
@en
39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
@nl
prefLabel
39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
@ast
39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
@en
39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
@nl
P2093
P2860
P356
P1476
39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
@en
P2093
P2860
P304
P356
10.1172/JCI116669
P407
P577
1993-08-01T00:00:00Z